Researcher
Bert Schepens
- Disciplines:Analytical biochemistry, Cell death and senescence, Analysis of next-generation sequence data, General diagnostics
Affiliations
- Saelens Lab (Research group)
Member
From1 Jan 2017 → Today
Publications
1 - 10 of 34
- Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted.(2024)
Authors: Bert Schepens, Sieglinde De Cae, Koen Sedeyn, Hannah Eeckhaut, Daria Fijalkowska, Kenny Roose, Nico Callewaert, Han Remaut, Xavier Saelens
Pages: 104960 - GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery.(2023)
Authors: Loes van Schie, Wander Van Breedam, Charlotte Roels, Bert Schepens, Iebe Rossey, Karel Thooft, Xavier Saelens, Nico Callewaert
Pages: 2210709 - Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies.(2022)
Authors: Teodora Oltean, Vera Goossens, Bert Schepens, Jonathan Maelfait, Nozomi Takahashi, Xavier Saelens, Peter Vandenabeele
Pages: 280 - An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.(2022)
Authors: Tessa Van Royen, Koen Sedeyn, Georgios Moschonas, Delphi Van Haver, Francis Impens, Sven Eyckerman, Irma Lemmens, Jan Tavernier, Bert Schepens, Xavier Saelens
Pages: e0129722 - How RSV Proteins Join Forces to Overcome the Host Innate Immune Response.(2022)
Authors: Tessa Van Royen, Iebe Rossey, Koen Sedeyn, Bert Schepens, Xavier Saelens
Pages: 419 - Single-domain antibodies make a difference.(2021)
Authors: Xavier Saelens, Bert Schepens
Pages: 681-682 - An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models(2021)
Authors: Bert Schepens, Loes van Schie, Wim Nerinckx, Kenny Roose, Wander Van Breedam, Simon Devos, Wannes Weyts, Sieglinde De Cae, Chiara Lonigro, Hannah Eeckhaut, et al.
Pages: eabi7826 - A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody.(2021)
Authors: Iebe Rossey, Koen Sedeyn, Marlies Ballegeer, Bert Schepens, Xavier Saelens
Pages: e02279-20 - Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.(2021)
Authors: Marlies Ballegeer, Emma Job, Kenny Roose, Bert Schepens, Lien Van Hoecke, Xavier Saelens
Pages: e0074521 - Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.(2020)
Authors: Dorien De Vlieger, Wander Van Breedam, Kenny Roose, Loes van Schie, Nico Callewaert, Bert Schepens, Xavier Saelens
Pages: 1004-1015.e15
Patents
1 - 8 of 8
- SARBECOVIRUS BINDERS (Inventor)
- ENGINEERED STABILIZING AGLYCOSYLATED FC-REGIONS (Inventor)
- CORONA VIRUS BINDERS (Inventor)
- CORONA VIRUS BINDERS (Inventor)
- PAN-SPECIFIC CORONA VIRUS BINDERS (Inventor)
- SARBECOVIRUS BINDERS (Inventor)
- ANTIBODY COMPOSITIONS FOR TREATMENT OF CORONA VIRUS INFECTION (Inventor)
- CORONA VIRUS BINDERS (Inventor)